Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis
Michael O. Harris‐Love(National Institutes of Health), Lisa G. Rider(United States Food and Drug Administration), Niraj Pahlajani(National Institutes of Health), Charles L. McGarvey(National Institutes of Health), B. Moini(National Institutes of Health), Robert Wesley(National Institutes of Health Clinical Center), Imelda Cabalar(National Institutes of Health), Joseph A. Shrader(National Institutes of Health Clinical Center), Frederick W. Miller(National Institutes of Health), Paul H. Plötz(National Institutes of Health), Dan Lovell(National Institutes of Health), Minal Jain(National Institutes of Health), Deloris E. Koziol(National Institutes of Health), M.L. Smith(National Institutes of Health), Holly Lea Cintas(National Institutes of Health), Laura James‐Newton(National Institutes of Health), Jeanne E. Hicks(Pain and Rehabilitation Medicine), Angelina Pokrovnichka(National Institutes of Health)
Cited by 132
Related Papers
Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
|New England Journal of Medicine|2006|902
Autoimmune-Associated Congenital Heart Block: Demographics, Mortality, Morbidity and Recurrence Rates Obtained From a National Neonatal Lupus Registry
|Journal of the American College of Cardiology|1998|748
Cushing’s Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years’ Experience at the National Institutes of Health
|The Journal of Clinical Endocrinology & Metabolism|2005|711